Department of Reproductive Medicine, The Maternal and Child Health Hospital of Changde City, 415000 Changde, Hunan, China.
Department of Reproductive Medicine Center, Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal Universtiy), 410000 Changsha, Hunan, China.
Rev Int Androl. 2024 Sep;22(3):68-73. doi: 10.22514/j.androl.2024.022. Epub 2024 Sep 30.
To investigate the role of fertilization (IVF) or intracytoplasmic sperm injection (ICSI) in cases with isolated teratozoospermia, and to provide reference for infertile patients to choose a reasonable insemination program. From January 2018 to December 2022, 433 couples received assisted reproductive assistance in the Department of Reproductive Medicine of our hospital. Among them, 81 patients presented isolated teratozoospermia (other sperm parameters were normal). These underwent IVF/ICSI, and differences in embryological data were compared between groups. 60 patients with moderate teratozoospermia went IVF, 11 needed rescue ICSI (R-ICSI, 18.33%), and 49 developed up to the blastocyst stage. 14 patients with severe teratozoospermia went IVF, 2 needed R-ICSI (14.29%), and 12 developed up to the blastocyst stage. There were no statistically significant differences in the proportion of R-ICSI between the two groups. Embryological outcomes were not significantly different between groups. The present results suggest that patients with moderate and severe teratozoospermia can be effectively treated with IVF, being R-ICSI performed when necessary.
为了探讨受精(IVF)或卵胞浆内单精子注射(ICSI)在单纯畸形精子症病例中的作用,为不孕患者选择合理的授精方案提供参考。 2018 年 1 月至 2022 年 12 月,我院生殖医学科共接受 433 对夫妇接受辅助生殖助孕。其中 81 例患者表现为单纯畸形精子症(其他精子参数正常)。这些患者进行了 IVF/ICSI,并比较了组间胚胎学数据的差异。60 例中度畸形精子症患者行 IVF,11 例需要挽救性 ICSI(R-ICSI,18.33%),49 例发育至囊胚阶段。14 例重度畸形精子症患者行 IVF,2 例需要 R-ICSI(14.29%),12 例发育至囊胚阶段。两组间 R-ICSI 的比例无统计学差异。组间胚胎学结局无显著差异。本研究结果表明,中重度畸形精子症患者可有效采用 IVF 治疗,必要时行 R-ICSI。